REG - GlaxoSmithKline PLC - Holding(s) in Company

GSKAnnouncement

19/11/2020 17:40

RNS Number : 9395F
  
GlaxoSmithKline PLC
  
19 November 2020
  
 





TR-1: Standard form for notification of major holdings




 




NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)




 




1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:


GlaxoSmithKline PLC




1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)




Non-UK issuer


 




2. Reason for the notification (please mark the appropriate box or boxes with an "X")




An acquisition or disposal of voting rights


X




An acquisition or disposal of financial instruments


 




An event changing the breakdown of voting rights


 




Other (please specify):


 




3. Details of person subject to the notification obligation




Name


The Capital Group Companies, Inc.




City and country of registered office (if applicable)


Los Angeles, USA




4. Full name of shareholder(s)  (if different from 3)




Name


 




City and country of registered office (if applicable)


 




5. Date on which the threshold was crossed or reached:


17/11/2020




6. Date on which issuer notified (DD/MM/YYYY):


19/11/2020




7. Total positions of person(s) subject to the notification obligation:




 


% of voting rights attached to shares
(total of 8.A)


% of voting rights through financial instruments
(total of 8.B.1 + 8.B.2)


Total of both in %
(8.A + 8.B)


Total number of voting rights of issuer




Resulting situation on the date on which threshold was crossed or reached


4.95%


0.00%


4.95%


5,017,424,632




Position of previous notification (if applicable)


5.04%


0.00%


5.04%


 



 
 
 
 
 
 
 




 





8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:




A: Voting rights attached to shares




Class/type of shares ISIN code (if possible)


Number of voting rights


% of voting rights




Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)


Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)




GB0009252882 Common Stock


 


200,251,814


 


3.99%




US37733W1053 Depository Receipt


 


48,292,050


 


0.96%




 


 


 


 


 




SUBTOTAL 8.A


248,543,864


4.95%




 




B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))




Type of financial instrument


Expiration date


Exercise/ Conversion Period


Number of voting rights that may be acquired if the instrument is exercised/converted


% of voting rights




N/A


 


 


 


 




 


 


SUBTOTAL 8.B.1


 


 




 




B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))




Type of financial instrument


Expiration date


Exercise/ Conversion Period


Physical or cash settlement


Number of voting rights


% of voting rights




N/A


 


 


 


 


 




 


 


 


SUBTOTAL 8.B.2


 


 



 
 
 
 
 
 
 




 





9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")




Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.


 




Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)


X




Name


% of voting rights if it equals or is higher than the notifiable threshold


% of voting rights through financial instruments if it equals or is higher than the notifiable threshold


Total of both if it equals or is higher than the notifiable threshold




Capital Research and Management Company


 


 


 




Capital Bank and Trust Company


 


 


 




Capital International, Inc.


 


 


 




Capital International Sàrl


 


 


 




Capital International Limited


 


 


 




Total


 


 


 




 




 




10. In case of proxy voting, please identify:




Name of the proxy holder


 




The number and % of voting rights held


 




The date until which the voting rights will be held


 




 




11. Additional information:


 




The Capital Group Companies, Inc. ("CGC") is the parent company of Capital Research and Management Company ("CRMC") and Capital Bank & Trust Company ("CB&T"). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. ("CGII"), which in turn is the parent company of four investment management companies ("CGII management companies"): Capital International, Inc., Capital International Limited, Capital International Sàrl and Capital International K.K. CGII management companies and CB&T primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based investment management company that is a registered investment adviser and an affiliated federally chartered bank.
Neither CGC nor any of its affiliates own shares of the Issuer for its own account. Rather, the shares reported on this Notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above.
 


 




 




Place of completion


Los Angeles




Date of completion


19/11/2020



 
 
 
 
 
 
 




 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
HOLBLBRTMTJBBPM